Sha Wang

Vivid Technologies

$363,265

Attributed

$363,265

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $214.2K · FY2018–20

$250K$187.5K$125K$62.5K$0

'18

'19

'20

Funding mix

By agency

NIH$363,265 · 2

By mechanism

R43$363,265 · 2

Top collaborators

No co-investigators on record.

Most similar at Vivid Technologies

Same institution · by research overlap

Km Wahidur Rahman$236,684

Others in their field

Other Emerging Leaders on “Animals”

Kevin Urdahl · Seattle Children'S Hospital$84,741,409
Ted Ross · University Of Georgia$70,992,558
Leonard Freedman · Leidos Biomedical Research, Inc.$63,986,959
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Sarah Fortune · Harvard School Of Public Health$51,119,645
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,241,299

Research focus

AnimalsAnti-CancerAnticancer ResearchAntineoplastic AgentsApoptosisApoptoticAreaBaseBioimagingBiological MarkersCaliberCell DeathCell NucleusCellsCharacteristicsCommercial ApplicationCost EffectiveDesignDetectionDna Double Strand BreakDna LigasesDna LigationDna TopoisomerasesAcanthamoeba

Grant awards (2)

New specific and rapid assay for in situ apoptosis labeling for cancer studies$214,214

R43 · FY2020 · CA · contact PI

In situ assay for RNA decapping in tumors$149,051

R43 · FY2018 · CA · contact PI